Buscar resultados de ensayos clínicos

Patrocinado por

Leukemia, Mast-Cell - 13 Studies Found

Estado Estudiar
Completed Nombre del estudio: Phase II Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD
Condición: Leukemia, Mast-Cell
Fecha: 2005-09-14
Intervenciones:
  • Procedure: nonmyeloablative allogeneic hematopoietic cell transplant

Active, not recruiting Nombre del estudio: Phase II Midostaurin in Aggressive Systemic Mastocytosis and Mast Cell Leukemia
Condición:
  • Systemic Mastocytosis, Aggressive (ASM)
  • Leukemia, Mast Cell Fecha: 2005-10-03
    Intervenciones: Drug: Midostaurin Midostaurin is a broad-spectrum protein kinase inhibitor, acting on conventional PKC i
Completed Nombre del estudio: Brentuximab Vedotin in Treating Patients With Advanced Systemic Mastocytosis or Mast Cell Leukemia
Condición:
  • Aggressive Systemic Mastocytosis
  • Mast Cell Leukemia
  • Fecha: 2013-03-05
    Intervenciones: Drug: brentuximab vedotin Brentuximab vedotin is an antibody with a covalently attached toxin. The antib
Active, not recruiting Nombre del estudio: Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia
Condición: Leukemia
Fecha: 2008-10-28
Intervenciones: Drug: Midostaurin (PKC412) Midostaurin was provided as 25 mg soft gelatin capsules for oral administrati
Completed Nombre del estudio: Ibrutinib in Treating Patients With Advanced Systemic Mastocytosis
Condición:
  • Aggressive Systemic Mastocytosis
  • Mast Cell Leukemia
  • Fecha: 2015-03-24
    Intervenciones:
    • Drug: Ibrutinib Given PO
Completed Nombre del estudio: Study of BLU-285 in Patients With Advanced Systemic Mastocytosis (advSM) and Relapsed or Refractory Myeloid Malignancies
Condición:
  • Aggressive Systemic Mastocytosis
  • Systemic Mastocytosis-associated Hematologic Non-mast Cell
    Fecha: 2015-09-15
    Intervenciones: Drug: BLU-285
Completed Nombre del estudio: Patient-Reported Outcome Questionnaire for Systemic Mastocytosis
Condición:
  • Aggressive Systemic Mastocytosis (ASM)
  • SM w Assoc Clonal Hema Non-mast Cell Lineage Disease
    Fecha: 2015-02-26
    Intervenciones: Other: Interview Single interview lasting approximately one hour
Completed Nombre del estudio: Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies
Condición:
  • Acute Undifferentiated Leukemia
  • Adult Acute Lymphoblastic Leukemia in Remission
  • Fecha: 2011-01-07
    Intervenciones:
    • Drug: deferasirox Given orally
Recruiting Nombre del estudio: Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer
Condición:
  • Acute Undifferentiated Leukemia
  • Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative
    • Fecha: 2009-05-09
    Intervenciones: Other: cytology specimen collection procedure Correlative studies
Terminated Nombre del estudio: Sunitinib in Treating Patients With Idiopathic Myelofibrosis
Condición:
  • Accelerated Phase Chronic Myelogenous Leukemia
  • Acute Undifferentiated Leukemia
  • Fecha: 2006-10-12
    Intervenciones: Drug: sunitinib malate Given PO
Next >>>